Impact BioMedical Inc.
AMEX: IBO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Frank D. Heuszel
- Employees
- 2
- Headquarters
- Houston, United States
- IPO year
- 2024
- Market cap
- $6.3M
- Website
- https://www.impactbiomedinc.com
Loading IBO…
Loading profile data…Frequently asked questions about IBO
What does Impact BioMedical Inc. (IBO) do?
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphen...
Where does IBO trade?
Impact BioMedical Inc. (IBO) trades on the New York Stock Exchange American.
What sector is IBO in?
Impact BioMedical Inc. (IBO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Impact BioMedical Inc.?
Frank D. Heuszel is the chief executive officer of Impact BioMedical Inc. (IBO).
Where is Impact BioMedical Inc. headquartered?
Impact BioMedical Inc. is headquartered in United States.
Does IBO pay a dividend?
Impact BioMedical Inc. (IBO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IBO go public?
Impact BioMedical Inc. (IBO) completed its initial public offering in 2024.